12/12/2024
4:23 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:55 PM | Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Scott Kathleen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:10 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/30/2024
4:22 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:01 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:06 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
5:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:00 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:09 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
4:16 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:26 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
5:45 PM | CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2024
4:22 PM | CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SC 13G | |
08/22/2024
3:42 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
7:31 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form ARS | |
07/22/2024
4:19 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form DEF 14A | |
07/18/2024
4:52 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:53 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
7:15 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:58 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form PRER14A | |
07/12/2024
6:19 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
4:21 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 424B3 | |
07/08/2024
11:15 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form EFFECT | |
06/27/2024
3:34 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form S-1/A | |
06/21/2024
3:14 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:54 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form S-1/A | |
05/13/2024
7:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
1:42 PM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SC 13G/A | |
04/29/2024
4:20 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 10-K/A | |
04/16/2024
2:07 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/11/2024
7:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
03/27/2024
3:55 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:02 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:11 PM | Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:14 PM | Gagnon Pierre (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:16 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:19 PM | Kim Yong Man (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:20 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Scott Kathleen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
12:05 PM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SC 13G | |
02/14/2024
5:28 AM | NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Radcliffe Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024
8:25 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/08/2024
4:07 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:31 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SC 13G/A | |
01/22/2024
5:12 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
6:50 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:19 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:14 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
